image goes here
Study Startup Success for the New Generation of Genetically Engineered Vaccines
The global COVID-19 pandemic has brought vaccine research to the forefront, and a surge of research involving genetically engineered vaccines is currently taking place. The availability of the viral genome and current genetic engineering techniques provide a wealth of opportunities for research and development of new vaccines. The most prominent COVID-19 vaccine candidates contain engineered genetic material, and gene-based cancer vaccines and genetically engineered immunotherapies are also booming.
However, studies involving investigational products containing engineered genetic materials also pose unique startup challenges. In this webinar, Advarra Director of Biosafety Services Daniel Eisenman introduces the latest trends in genetically modified vaccine and immunotherapy studies. His presentation also explores obstacles to study startup and strategies to keep research moving forward.
- Describe current trends in genetically modified vaccines and immunotherapy research
- Identify study startup obstacles for these studies
- Outline strategies for overcoming challenges in research involving genetic engineering
PhD, RBP, SM(NRCM), CBSP
Director of Biosafety Services
Who should watch?
This content applies to research professionals representing sponsors, CROs, institutions, and sites who are involved in research pertaining to infectious disease vaccines, oncology, immune therapy and gene therapy.
Attendance at this session has been approved for 1.00 contact hour of research specific continuing education on applications for Maintenance of ACRP’s CCRC®, CCRA®, CPI®, or ACRP-CP® certification designations.
Provider approved by the California Board of Registered Nursing, Provider Number 16549, for 1 contact hour. This documentation must be retained by the licensee for a period of 4 years after the course concludes.
The Society of Clinical Research Associates (SOCRA - www.SOCRA.org) accepts documentation of candidate participation in continuing education programs for recertification if the program is applicable to clinical research regulations, operations or management, or to the candidate’s clinical research therapeutic area. This program offers 1 hour of CE credit.
If you would like to obtain CE credits for a different credential, please check with your professional organization to determine if our webinars meet their continuing education requirements.
Certificate of Attendance
After watching this webinar in its entirety and completing the webinar survey, you will receive a certificate of attendance. This certificate will be emailed to you within one business day of watching the webinar. Please note that if your organization has other staff members who wish to get a certificate of attendance, each person must register, watch the webinar in its entirety, and complete the webinar survey. Visit our Webinar Help page for more information on certificates of attendance.
DATE: July 8, 2020
Time: 1 pm ET | 10 am PT
Duration: 1 hour